|Bid||33.59 x 1400|
|Ask||33.60 x 1300|
|Day's Range||33.44 - 33.90|
|52 Week Range||24.10 - 46.62|
|Beta (5Y Monthly)||0.98|
|PE Ratio (TTM)||12.90|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Boston Scientific recalled its Lotus Edge transcatheter heart-valve replacement system on Tuesday — sending BSX stock into a tailspin. The medical device gained FDA approval in 2019.
Boston Scientific is lower after the medical-device maker stops producing its Lotus Edge Aortic Valve due to issues with its delivery system.